Market Overview:
The global medical grade sodium alginate market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The high viscosity segment is expected to grow at the highest CAGR during the forecast period. The growth in this segment can be attributed to the increasing demand for medical grade sodium alginate for tissue engineering and cell culture applications. North America is expected to dominate the market during the forecast period, followed by Europe and Asia Pacific.
Product Definition:
Sodium alginate is a natural polymer extracted from brown seaweed. It is used as a thickener, binder and emulsifier in food and pharmaceuticals. Sodium alginate can also be used to form gels for encapsulating or suspending particles.
Low Viscosity Below 150 mpa.s:
Low viscosity below 150 mpa.s is a colloidal hydrogel that contains sodium alginate and is used as an additive in medical-grade sodium alginate. It has applications in ophthalmic, dental, and orthopedic surgeries due to its low shearing force properties.
Medium Viscosity 150-400 mpa.s:
Medium viscosity 150-400 mpa.s is a transparent, semi-solid hydrocolloid substance derived from the extraction of alginic acid. It has several applications in medical and pharmaceutical industries owing to its unique properties such as it can absorb or hold water, it can also be easily removed from the surface by water or other solvents and lastly it has an excellent ability to bind with other substances.
Application Insights:
The other application segment of the global medical grade sodium alginate market includes food and beverage, textile processing, textiles treatment, water treatment and others. The product finds extensive usage in the textile industry for treating fabric during washing & drying processes to enhance fabric life. It is also used as a sizing agent in various applications such as technical textiles, fashion wearables & accessories and home furnishing fabrics among others.
The product has high demand from pharmaceutical preparation due to its ability to form gels that are stable over a wide range of temperatures without compromising with drug solubility or efficacy. It is used for making solutions that are ideal for deep-tissue injections owing to its high viscosity index which ranges between 150-400 mpa.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to witness a growth rate of 5.6% over the forecast period, owing to increasing demand for pharmaceutical products and tissue engineering applications in North America. Asia Pacific is anticipated to be one of the fastest-growing regional markets from 2018 to 2030 due to rapid industrialization and economic development along with rising healthcare spending in emerging countries such as China, India, Thailand, Malaysia & Indonesia etc.
China was one of the largest producers as well as consumers for sodium alginate globally on account of easy access and availability at low cost coupled with high production capacity present within country limits thus making it an ideal manufacturing base for many international manufacturers who set up their plants within China itself or nearby countries such as South Korea & Japan etc.
Growth Factors:
- Increasing demand for medical grade sodium alginate from wound care and tissue engineering applications
- Rising prevalence of chronic diseases, which is expected to increase the demand for medical grade sodium alginate products
- Growing number of surgical procedures, which is anticipated to boost the use of medical grade sodium alginate in various applications
- Technological advancements in the field of wound care and tissue engineering that would lead to increased adoption of medical grade sodium alginate products
- Rising awareness about benefits offered by medical grade sodium alginate products
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical Grade Sodium Alginate Market Research Report
By Type
Low Viscosity Below 150 mpa.s, Medium Viscosity 150-400 mpa.s, High Viscosity Above 400 mpa.s
By Application
Pharmaceutical Preparation, Tissue Engineering, Cell Culture, Other
By Companies
KIMICA Corporation, Jiejing Group, Gather Great Ocean Seaweed Industry, Allforlong Bio-Tech Company, Yantai Xinwang Seaweed
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Medical Grade Sodium Alginate Market Report Segments:
The global Medical Grade Sodium Alginate market is segmented on the basis of:
Types
Low Viscosity Below 150 mpa.s, Medium Viscosity 150-400 mpa.s, High Viscosity Above 400 mpa.s
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Preparation, Tissue Engineering, Cell Culture, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- KIMICA Corporation
- Jiejing Group
- Gather Great Ocean Seaweed Industry
- Allforlong Bio-Tech Company
- Yantai Xinwang Seaweed
Highlights of The Medical Grade Sodium Alginate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Low Viscosity Below 150 mpa.s
- Medium Viscosity 150-400 mpa.s
- High Viscosity Above 400 mpa.s
- By Application:
- Pharmaceutical Preparation
- Tissue Engineering
- Cell Culture
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical Grade Sodium Alginate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Medical grade sodium alginate is a type of salt that is derived from the seaweed alga, Alginia officinalis. It is used as an absorbent and thickening agent in medical treatments.
Some of the key players operating in the medical grade sodium alginate market are KIMICA Corporation, Jiejing Group, Gather Great Ocean Seaweed Industry, Allforlong Bio-Tech Company, Yantai Xinwang Seaweed.
The medical grade sodium alginate market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Medical Grade Sodium Alginate Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Medical Grade Sodium Alginate Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Medical Grade Sodium Alginate Market - Supply Chain
4.5. Global Medical Grade Sodium Alginate Market Forecast
4.5.1. Medical Grade Sodium Alginate Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Medical Grade Sodium Alginate Market Size (000 Units) and Y-o-Y Growth
4.5.3. Medical Grade Sodium Alginate Market Absolute $ Opportunity
5. Global Medical Grade Sodium Alginate Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Medical Grade Sodium Alginate Market Size and Volume Forecast by Type
5.3.1. Low Viscosity Below 150 mpa.s
5.3.2. Medium Viscosity 150-400 mpa.s
5.3.3. High Viscosity Above 400 mpa.s
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Medical Grade Sodium Alginate Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Medical Grade Sodium Alginate Market Size and Volume Forecast by Application
6.3.1. Pharmaceutical Preparation
6.3.2. Tissue Engineering
6.3.3. Cell Culture
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Medical Grade Sodium Alginate Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Medical Grade Sodium Alginate Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Medical Grade Sodium Alginate Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Medical Grade Sodium Alginate Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Medical Grade Sodium Alginate Demand Share Forecast, 2019-2026
9. North America Medical Grade Sodium Alginate Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Medical Grade Sodium Alginate Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Medical Grade Sodium Alginate Market Size and Volume Forecast by Application
9.4.1. Pharmaceutical Preparation
9.4.2. Tissue Engineering
9.4.3. Cell Culture
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Medical Grade Sodium Alginate Market Size and Volume Forecast by Type
9.7.1. Low Viscosity Below 150 mpa.s
9.7.2. Medium Viscosity 150-400 mpa.s
9.7.3. High Viscosity Above 400 mpa.s
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Medical Grade Sodium Alginate Demand Share Forecast, 2019-2026
10. Latin America Medical Grade Sodium Alginate Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Medical Grade Sodium Alginate Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Medical Grade Sodium Alginate Market Size and Volume Forecast by Application
10.4.1. Pharmaceutical Preparation
10.4.2. Tissue Engineering
10.4.3. Cell Culture
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Medical Grade Sodium Alginate Market Size and Volume Forecast by Type
10.7.1. Low Viscosity Below 150 mpa.s
10.7.2. Medium Viscosity 150-400 mpa.s
10.7.3. High Viscosity Above 400 mpa.s
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Medical Grade Sodium Alginate Demand Share Forecast, 2019-2026
11. Europe Medical Grade Sodium Alginate Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Medical Grade Sodium Alginate Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Medical Grade Sodium Alginate Market Size and Volume Forecast by Application
11.4.1. Pharmaceutical Preparation
11.4.2. Tissue Engineering
11.4.3. Cell Culture
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Medical Grade Sodium Alginate Market Size and Volume Forecast by Type
11.7.1. Low Viscosity Below 150 mpa.s
11.7.2. Medium Visosity 150-400 mpa.s
11.7.3. High Viscosity Above 400 mpa.s
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Medical Grade Sodium Alginate Demand Share, 2019-2026
12. Asia Pacific Medical Grade Sodium Alginate Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Medical Grade Sodium Alginate Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Medical Grade Sodium Alginate Market Size and Volume Forecast by Application
12.4.1. Pharmaceutical Preparation
12.4.2. Tissue Engineering
12.4.3. Cell Culture
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Medical Grade Sodium Alginate Market Size and Volume Forecast by Type
12.7.1. Low Viscosity Below 150 mpa.s
12.7.2. Medium Viscosity 150-400 mpa.s
12.7.3. High Viscosity Above 400 mpa.s
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Medical Grade Sodium Alginate Demand Share, 2019-2026
13. Middle East & Africa Medical Grade Sodium Alginate Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Medical Grade Sodium Alginate Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Medical Grade Sodium Alginate Market Size and Volume Forecast by Application
13.4.1. Pharmaceutical Preparation
13.4.2. Tissue Engineering
13.4.3. Cell Culture
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Medical Grade Sodium Alginate Market Size and Volume Forecast by Type
13.7.1. Low Viscosity Below 150 mpa.s
13.7.2. Medium Viscosity 150-400 mpa.s
13.7.3. High Viscosity Above 400 mpa.s
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Medical Grade Sodium Alginate Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Medical Grade Sodium Alginate Market: Market Share Analysis
14.2. Medical Grade Sodium Alginate Distributors and Customers
14.3. Medical Grade Sodium Alginate Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. KIMICA Corporation
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Jiejing Group
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Gather Great Ocean Seaweed Industry
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Allforlong Bio-Tech Company
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Yantai Xinwang Seaweed
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
